Search Results

Galatea Bio Secures $25M to Develop Global Biobank and Enable Precision Health at Scale for All Galatea Bio Secures $25M to Develop Global Biobank and Enable Precision Health at Scale for All

Galatea Bio Launches StrataRisk™ Polygenic Risk Score to Scale Common Disease Risk Assessment and Reporting at the 2025 ACMG Conference MIAMI LAKES, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Galatea Bio, a leader in precision health, announced today the launch of StrataRisk™, a Polygenic Risk Score (PRS) Software-as-a-Service (SaaS)...